tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RHHVF Stock Latest News

Genentech announces CENTERSTONE study meets primary endpoint
The FlyGenentech announces CENTERSTONE study meets primary endpoint
8h ago
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
PremiumPress Releases
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
12h ago
FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
PremiumPress Releases
FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
4d ago
FDA approves Genentech’s Ocrevus Zunovo
PremiumThe Fly
FDA approves Genentech’s Ocrevus Zunovo
6d ago
Boeing factory workers strike halts 737 MAX production: Morning Buzz
PremiumThe Fly
Boeing factory workers strike halts 737 MAX production: Morning Buzz
6d ago
BA
RH
Roche downgraded to Sell from Hold at Deutsche Bank
PremiumThe FlyRoche downgraded to Sell from Hold at Deutsche Bank
6d ago
Roche upgraded to Buy from Neutral at BofA
Premium
The Fly
Roche upgraded to Buy from Neutral at BofA
6d ago
FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy
Premium
Press Releases
FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy
7d ago
FDA approves Genentech’s Tecentriq Hybreza in cancer treatment
PremiumThe Fly
FDA approves Genentech’s Tecentriq Hybreza in cancer treatment
7d ago
After Roche data, Morgan Stanley says Viking VK2735 has best-in-class potential
PremiumThe Fly
After Roche data, Morgan Stanley says Viking VK2735 has best-in-class potential
7d ago
VKTX
Roche obesity pill tied to high rates of nausea in ST study, Bloomberg says
PremiumThe Fly
Roche obesity pill tied to high rates of nausea in ST study, Bloomberg says
7d ago
LLY
NVO
Novo amycretin safety ‘not quite as clean as we’d like,’ says Deutsche Bank
PremiumThe Fly
Novo amycretin safety ‘not quite as clean as we’d like,’ says Deutsche Bank
8d ago
NVO
Roche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
PremiumPress ReleasesRoche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
9d ago
Roche integrates more than 20 advanced AI algorithms
Premium
The Fly
Roche integrates more than 20 advanced AI algorithms
10d ago
Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial
Premium
The Fly
Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial
14d ago
PSTX
Roche to present data for fenebrutinib from Phase II FENopta OLE study
PremiumThe Fly
Roche to present data for fenebrutinib from Phase II FENopta OLE study
15d ago
Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis
PremiumPress Releases
Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis
15d ago
Trinity Biotech names Adrian Donohue as Chief Commercial Officer
PremiumThe Fly
Trinity Biotech names Adrian Donohue as Chief Commercial Officer
16d ago
LLY
TRIB
Truist biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Truist biotech analysts hold an analyst/industry conference call
22d ago
IONS
RARE
Roche announces PiaSky approved in EU for people with PNH
PremiumThe FlyRoche announces PiaSky approved in EU for people with PNH
23d ago
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
Premium
Press Releases
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
24d ago
Roche announces it will support response to mpox global health emergency
Premium
The Fly
Roche announces it will support response to mpox global health emergency
1M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >